<?xml version="1.0" encoding="UTF-8"?>
<p>Convalescent plasma (CP) therapy is a classic adaptive immunotherapy that has been used for decades in the prevention and treatment of various diseases. CP was used in prior epidemics including SARS-CoV, MERS-CoV, and H1N1 in 2009 and it showed successful results with a safe profile (
 <xref rid="B111" ref-type="bibr">111</xref>). Given the similarity between SARS-CoV-2, SARS-CoV, and MERS-CoV, CP may have potential efficacy in this current pandemic. However, no RCTs involving CP in SARS-CoV-2 infection have been completed as of yet, and hence the risks and benefits remain unclear.
</p>
